ClinicalTrials.gg
CompletedNCT07769723Updated Aug 19, 2026

Simulation-Based Education and Caregiving Ability Among Families of Stunted Children

An interventional study of Simulation-Based Education and Standardized Growth and Development Education Module in Stunting, sponsored by Universitas Muhammadiyah Tasikmalaya. Completed at 1 site in Indonesia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Universitas Muhammadiyah Tasikmalaya · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Apr 2026, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Stunting can affect children's growth and development and requires not only nutritional management but also appropriate stimulation and responsive caregiving. This study evaluated whether adding simulation-based growth and development education to a standard educational module could improve the caregiving ability of families with stunted children. Caregivers received either a standardized take-home module alone or the same module combined with simulation-based education. The study assessed changes in caregivers' knowledge and self-reported ability to perform developmental stimulation activities.

Read the detailed description

This study was a nonrandomized quasi-experimental study using a pretest-posttest control group design. The study was conducted among family caregivers of children with stunting aged 1-3 years in the working area of Tamansari Public Health Center, Tasikmalaya, Indonesia.

Participants were allocated based on geographical areas. The control group received a standardized growth and development education module to use at home. The intervention group received the same module plus simulation-based education. The simulation session included explanation of child growth and development concepts, demonstration of developmental stimulation activities, guided caregiver practice, and corrective feedback from the facilitator.

The study included 55 caregivers in the final analysis, consisting of 31 caregivers in the intervention group and 24 caregivers in the control group. Caregiving ability was assessed in two domains: cognitive ability measured using a 32-item instrument and self-reported psychomotor ability measured using a 20-item questionnaire.

The primary purpose of this study was to determine whether simulation-based education provides additional benefits compared with module-only education in improving caregiver knowledge and perceived ability to perform developmental stimulation activities for children with stunting.

The study received ethical approval from the Health Research Ethics Committee, Faculty of Nursing and Health Sciences, Universitas Muhammadiyah Semarang (Ethical Clearance No. 001/KE/05/2026). Participation was voluntary, and all participants provided written informed consent before joining the study.

02

Conditions studied

  • Stunting

Browse trials for

Keywords

  • Stunting
  • simulation
  • caregiver education
  • developmental stimulation
  • caregiving ability
03

In context

Growth Disorders

227 studies on the registry are indexed under Growth Disorders; 25 are open to participants now.

This study's enrollment of 55 is below the median of 413 across 143 interventional studies indexed under Growth Disorders.

Browse Growth Disorders studies →

Lead sponsor

This is the only study on the registry with Universitas Muhammadiyah Tasikmalaya as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Family caregivers of children aged 1-3 years diagnosed with stunting.
  2. The caregiver is the primary person responsible for daily child care.
  3. The caregiver lives with the child during the study period.
  4. The caregiver is willing to participate and provide written .
  5. The caregiver is able to communicate and complete the study questionnaire.

Exclusion criteria

Exclusion Criteria:

  1. Caregivers who cannot participate in the educational sessions.
  2. Caregivers who have communication barriers that prevent completion of the assessment.
  3. Participants who withdraw consent during the study period.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
55 participants (actual)

Study arms

  • Experimental
    Simulation-Based Education Group

    Participants received a standardized growth and development education module combined with simulation-based education. The simulation included explanation, demonstration, caregiver practice, and corrective feedback regarding developmental stimulation activities for children with stunting.

    Behavioral: Simulation-Based Education · Behavioral: Standardized Growth and Development Education Module

  • Active comparator
    Module-Only Group

    Participants received the standardized growth and development education module only without simulation-based education.

    Behavioral: Standardized Growth and Development Education Module

Interventions

  • BehavioralSimulation-Based Education

    A simulation-based educational intervention consisting of growth and development education, demonstration of developmental stimulation activities, guided caregiver practice, and corrective feedback.

  • BehavioralStandardized Growth and Development Education Module

    A standardized educational module about child growth, development, and caregiving practices provided to caregivers as take-home educational material.

06

What researchers measure

Primary outcomes

  1. Caregiver Ability in Providing Care for Children with Stunting

    The primary outcome was caregiver ability in caring for children with stunting, consisting of cognitive ability and self-reported psychomotor ability related to child growth and development stimulation practices.

    Time frame: Immediately after the intervention (posttest)

Secondary outcomes

  1. Caregiver Cognitive Ability

    Caregiver cognitive ability was assessed using a 32-item instrument measuring knowledge related to child growth, development, and stimulation practices.

    Time frame: Immediately after the intervention (posttest)

  2. Caregiver Self-Reported Psychomotor Ability

    Caregiver self-reported psychomotor ability was assessed using a 20-item questionnaire evaluating the ability to perform developmental stimulation activities.

    Time frame: Immediately after the intervention (posttest)

07

Study locations

1 site
  • Puskesmas Tamansari
    Tasikmalaya, West Java 46196, Indonesia
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers because the dataset contains confidential information from participants. Data access is restricted to the research team and will only be used for the purposes described in the approved study protocol. Any dissemination of findings will be conducted using aggregated results without identifying individual participants.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07769723
Lead sponsor
Universitas Muhammadiyah Tasikmalaya
Responsible party
Sponsor
First posted
Aug 18, 2026
Start date
Apr 10, 2026
Primary completion
May 26, 2026
Completion
May 26, 2026
Last update
Aug 19, 2026

Study contacts

NIA RESTIANA, M.Kep
principal investigator · Universitas Muhammadiyah Tasikmalaya
Neni Solihat, M.Psi
study director · Universitas Muhammadiyah Tasikmalaya
Rosy Rosnawanty, M.Kep
study director · Universitas Muhammadiyah Tasikmalaya

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion